Cronos Intangible Assets Over Time
| CRON Stock | USD 2.13 0.05 2.40% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Cronos Performance and Cronos Correlation. Cronos |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cronos. If investors know Cronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cronos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.144 | Earnings Share (0.12) | Revenue Per Share 0.267 | Quarterly Revenue Growth 0.46 | Return On Assets (0.04) |
The market value of Cronos Group is measured differently than its book value, which is the value of Cronos that is recorded on the company's balance sheet. Investors also form their own opinion of Cronos' value that differs from its market value or its book value, called intrinsic value, which is Cronos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cronos' market value can be influenced by many factors that don't directly affect Cronos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cronos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cronos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cronos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Intangible Assets Analysis
Compare Cronos Group and related stocks such as OrganiGram Holdings, Aurora Cannabis, and SNDL Inc Intangible Assets Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OGI | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.5 M | 1.8 M | 2.7 M | 14.3 M | 10.6 M | 12.2 M | 12.8 M |
| ACB | 36.7 K | 36.7 K | 36.7 K | 36.7 K | 298.4 K | 282 K | 31.1 M | 256.2 M | 688.4 M | 412.3 M | 367.4 M | 70.7 M | 61.4 M | 40.9 M | 38.8 M |
| SNDL | 522.5 K | 522.5 K | 522.5 K | 522.5 K | 522.5 K | 522.5 K | 522.5 K | 522.5 K | 0.0 | 44 M | 5.1 M | 4.7 M | 74.9 M | 73.1 M | 76.8 M |
| CGC | 63.4 K | 63.4 K | 63.4 K | 63.4 K | 57.5 K | 31.9 M | 162.3 M | 101.5 M | 519.6 M | 476.4 M | 308.2 M | 252.7 M | 188.7 M | 104.1 M | 57.5 K |
| TLRY | 60 K | 60 K | 60 K | 60 K | 60 K | 3.3 M | 1.4 M | 175.6 M | 289.8 M | 261.7 M | 1.6 B | 1.3 B | 973.8 M | 915.5 M | 550.5 M |
Cronos Group and related stocks such as OrganiGram Holdings, Aurora Cannabis, and SNDL Inc Intangible Assets description
Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.My Equities
My Current Equities and Potential Positions
Check out Cronos Performance and Cronos Correlation. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Cronos technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.